[Federal Register Volume 60, Number 148 (Wednesday, August 2, 1995)]
[Notices]
[Page 39396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-18953]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
[Dkt. C-3586]
Glaxo plc; Prohibited Trade Practices, and Affirmative Corrective
Actions
AGENCY: Federal Trade Commission.
ACTION: Consent order.
-----------------------------------------------------------------------
SUMMARY: In settlement of alleged violations of federal law prohibiting
unfair acts and practices and unfair methods of competition, this
consent order requires, among other things, a British drug company to
divest, within nine months, Wellcome's worldwide research and
development assets for non-injectable drugs, or else agree to have a
Commission-appointed trustee to complete the transaction. In addition,
the consent order requires Glaxo, for a period of ten years, to obtain
Commission approval before acquiring more than one percent interest in
any entity involved in the clinical development, manufacture or sale of
migraine drugs.
DATES: Complaint and Order issued June 14, 1995.\1\
\1\ Copies of the Complaint and the Decision and Order are
available from the Commission's Public Reference Branch, H-130, 6th
Street & Pennsylvania Avenue, NW., Washington, DC 20580.
---------------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT:
Claudia Higgins or Ann Malester, FTC/S-2224, Washington, DC 20580.
(202) 326-2682.
SUPPLEMENTARY INFORMATION: On Wednesday, March 29, 1995, there was
published in the Federal Register, 60 FR 16139, a proposed consent
agreement with analysis In the Matter of Glaxo plc, for the purpose of
soliciting public comment. Interested parties were given sixty (60)
days in which to submit comments, suggestions or objections regarding
the proposed form of the order.
No comment have been received, the Commission has ordered the
issuance of the complaint in the form contemplated by the agreement,
made its jurisdictional findings and entered an order to divest, as set
forth in the proposed consent agreement, in disposition of this
proceeding.
(Sec. 6, Stat. 721; 15 U.S.C. 46. Interpret or apply sec. 5, 38
Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended; 15 U.S.C.
45, 18)
Benjamin I. Berman,
Acting Secretary.
[FR Doc. 95-18953 Filed 8-1-95; 8:45 am]
BILLING CODE 6750-01-M
